One common dilemma faced by psychiatric nurse practitioners is determining who the “client” is. Given that children are typically brought for treatment by their parents, describe how the psychiatric nurse practitioner would respond to a child who discloses they are indulging in illicit behavior and asks you not to tell his or her parents.
Your initial post should be at least 500 words, formatted, and cited in current APA style with support from at least 2 academic sources.
Objective: This discussion post aims to explore the concepts of hunger and food insecurity, and to analyze nutrition assistance programs that address food insecurity among different population groups in the United States.
Discussion Questions:
1-Define Hunger and Food Insecurity
2-Differences Between Hunger and Food Insecurity:
3-Select two nutrition assistance programs that address food insecurity among different population groups in the United States. For each program, provide the following information:
4. Critical Analysis:
5.Conclusion:
As a reminder, all discussion posts must be a minimum of 2 PAGES references must be cited in APA format 7th Edition, and must include a minimum of 2 scholarly resources published within the past 5 years.
DUE DATE : WEDNESDAY MARCH 19, 2025 NO LATER
NO PALGIO MORE THAN 10% ACCEPTED
Compare the primary care NP role with other APN roles. What are the similarities among the roles, what are the differences, and how would you communicate the role to a healthcare provider and a consumer?
Submission Instructions:
References not older than 6 years
i will have to submit it to turn it in
no chat gbt
rubric
Discussion Rubric
Discussion Rubric
CriteriaRatingsPts
This criterion is linked to a Learning OutcomeIdentification of Main Issues, Problems, and Concepts
5 ptsDistinguished
Identify and demonstrate a sophisticated understanding of the issues, problems, and concepts.
4 ptsExcellent
Identifies and demonstrate an accomplished understanding of most of issues, problems, and concepts.
2 ptsFair
Identifies and demonstrate an an acceptable understanding of most of issues, problems, and concepts.
1 ptsPoor
Identifies and demonstrate an unacceptable understanding of most of issues, problems, and concepts.
5 pts
This criterion is linked to a Learning OutcomeUse of Citations, Writing Mechanics and APA Formatting Guidelines
3 ptsDistinguished
Effectively uses the literature and other resources to inform their work. Exceptional use of citations and extended referencing. High level of APA precision and free of grammar and spelling errors.
2 ptsExcellent
Effectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. Moderate level of APA precision and free of grammar and spelling errors.
1 ptsFair
Ineffectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. APA style and writing mechanics need more precision and attention to detail.
0 ptsPoor
Ineffectively uses the literature and other resources to inform their work. An unacceptable use of citations and extended referencing. APA style and writing mechanics need serious attention.
3 pts
This criterion is linked to a Learning OutcomeResponse to Posts of Peers
2 ptsDistinguished
Student constructively responded to two other posts and either extended, expanded or provided a rebuttal to each.
1 ptsFair
Student constructively responded to one other post and either extended, expanded or provided a rebuttal.
0 ptsPoor
Student provided no response to a peer’s post.
2 pts
Total Points: 10
After studying Module 1: Lecture Materials & Resources, discuss the following in a single post:
Spiritual Autobiography & Genealogy
Share the following content with your classmates to the extent that you feel comfortable. If you prefer to share a more complete version with your professor only, then email the full version to them directly:
Note: When completing this assignment, why not use the Media RecorderLinks to an external site. to create a video or link to a YouTube videoLinks to an external site. to answer the questions above?
Submission Instructions:
Please ensure that the Discussion includes more than 200 words with scholarly articles, and the plagiarism level must remain below 20%.
Mounjaro vs Ozempic: A Guide to Two Endocrine Disorder Treatments
Well-established pharmacological agents have made considerable advances in treating endocrine disorders, precisely type 2 diabetes mellitus (T2DM) and obesity. Newer agents, such as Mounjaro (tirzepatide) and Ozempic (semaglutide), are well-known for their blood sugar-regulating and weight loss-promoting effects. Both agents are incretin-based therapies but have unique pharmacological profiles that affect their clinical use.
Similarities
Mounjaro and Ozempic have many similarities, including their mechanism of action and therapeutic benefits. Both agents, as incretin mimetics, act on the glucagon-like peptide-1 (GLP-1) receptor to increase insulin release, decrease glucagon secretion, and delay gastric emptying, ultimately resulting in better control of blood sugar levels. (Jastreboff et al., 2022). Furthermore, both Exenatide and Semaglutide are injected subcutaneously and have demonstrated clinically meaningful weight loss in people with T2DM and obesity (Garber, 2022). These similarities underline their potential for aiding in ameliorating blood glucose levels and the more general metabolic derangements accompanying obesity and diabetes.
Differences
While they have similarities, Mounjaro and Ozempic vary in some important ways. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, while Ozempic (semaglutide) is a specific GLP-1 receptor agonist (Frías et al., 2021). Mounjaro’s extra GIP receptor activity provides better insulin secretion and potential additional weight loss benefits than Ozempic. Clinical trials have indicated that tirzepatide may significantly reduce HbA1c and body weight more than semaglutide (Jastreboff et al., 2022). Additionally, there are also differences in dosing; Ozempic is started at a lower dose (0.25 mg weekly) and titrated to a maximum of 2 mg weekly, while Mounjaro is available in a range of doses (2.5 mg to 15 mg weekly) to suit different patient needs (Garber, 2022).
Clinical Implications
Introducing Mounjaro and Ozempic is initiating a new phase in T2DM and obesity management. The improved weight loss and glycemic control with Mounjaro could translate into preferential usage in patients needing more robust metabolic agents. However, healthcare providers need to consider cost, willingness to take medication, and risk of complications such as gastrointestinal disturbance for proper therapy. More studies are necessary on these agents’ long-term safety and cardiovascular impact.
Conclusion
Mounjaro and Ozempic are valuable agents in the pharmacologic management of diabetes and obesity, respectively; because these medications have different mechanisms of action and clinical effects, individualized treatment decisions are needed to provide the best possible patient results.
References
Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., & Liu, B. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. https://doi.org/10.1056/NEJMoa2107519
Garber, A. J. (2022). Incretin-based therapies in managing type 2 diabetes: Role of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists. Diabetes Care, 45(Suppl 1), S219-S227. https://doi.org/10.2337/dc21-S014
Jastreboff, A. M., Kaplan, L. M., Frías, J. P., Wu, Q., Du, Y., Sturm, K., & Hompesch, M. (2022). Effects of tirzepatide on body weight in people with obesity: A phase 3 trial. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038
Semaglutide vs Trizepatide. https://www.premieraestheticsva.com/post/semaglutide-vs-trizepatide
Please ensure that the Discussion includes more than 200 words with scholarly articles, and the plagiarism level must remain below 20%.
For the treatment of diabetes mellitus (DM) type 2 and obesity the pharmacology has noted significant advances in these fields. There are two new medications to come on the endocrinology scenario that are called Mounjaro (tripeptide) and Ozempic (semaglutide) because of their efficacy in these conditions DM type 2 and obesity. Both drugs are glucagon-like peptide 1 (GLP-1) receptor agonists, which imitate the natural GLP-1 hormone that helps to control the blood sugar and appetite. Like drugs, they have detailed differences: their mechanisms of action and the variety of conditions they treat will have clinical implications for their use in endocrine disorders. An important similarity between Mounjaro and Ozempic is that they act on the GLP-1 receptor, which helps regulate insulin liberation and glucagon release in response to food intake. This is about better blood sugar control. Thus, these are highly effective in treating type 2 diabetes (Latif et al., 2021). Moreover, both drugs help in weight loss, which is a key of the managing obesity frequently associated with type 2 diabetes. Clinical investigation of these two medications have shown that they guide the substantial decreases in HbA1c (a marker of long-term blood sugar control) and body weight and, therefore, are beautiful treatment options for patients with both conditions.
However, the principal difference with the Mounjaro and Ozempic is how they work. Mounjaro, in the manuscript, was described as a doble agonist of the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor (Zheng et al., 2024). Another hormone that regulates insulin and glucose metabolism is Mounjaro, and it has the added capacity to target both GLP-1 and GIP receptors, expanding its potential effect on reducing blood sugar and weighing down on our overall body weight more than a single GLP1 receptor agonist like Ozempic. Its enhanced signal is expected to guide to more effective treatment options for type 2 diabetes and maturity-related conditions.
There are many clinical implications and differences for healthcare providers using Mounjaro or Ozempic for the patients. Compared to other options, Mounjaro is more likely to be better for someone with more extreme type 2 diabetes or obesity because it has higher efficacy when it comes to both lowering blood sugar and weight loss (Zheng et al., 2024). While Ozempic is generally better studied, it has a better safety and efficacy profile, which you may prefer over the GLP 1 receptor agonists in patients who do well with them or patients who require a more well-studied medication. Both drugs can cause gastrointestinal problems, but Mounjaro’s dual activity might carry a very slightly higher chance of problems. Consequently, these medications will be compared, and finally, the choice will be made based on the patient’s characteristics (response and tolerance to the possible side effects of treatment and the severity of the condition).
Mounjaro and Ozempic are both efficacious, but both hold potential clinical complications. The risk of pancreatitis inflammation of the pancreas is one primary concern because GLP-1 receptor agonists have been associated with pancreatitis (Ayoub et al., 2025). Patients with pancreatitis background should be provided these drugs, and they should be closely monitored. In fact, another gastrointestinal symptom such nausea, vomiting, and diarrhea are very frequent, and some patients have more serious side effects that make difficult for patient to follow the treatment. Compared to Ozempic, Mounjaro’s dual action might make stomach pain more likely.
References
Ayoub, M., Chela, H., Amin, N., Hunter, R., Anwar, J., Tahan, V., & Daglilar, E. (2025). Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis. Journal of Clinical Medicine, 14(3), 944. https://doi.org/10.3390/jcm14030944
Latif, W., Lambrinos, K. J., & Rodriguez, R. (2021). Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs). https://www.ncbi.nlm.nih.gov/books/NBK572151/
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024). Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduction and Targeted Therapy, 9(1), 234. https://www.nature.com/articles/s41392-024-01931-z
Hematopoietic:
J.D. is a 37 years old white woman who presents to her gynecologist complaining of a 2-month history of intermenstrual bleeding, menorrhagia, increased urinary frequency, mild incontinence, extreme fatigue, and weakness. Her menstrual period occurs every 28 days and lately there have been 6 days of heavy flow and cramping. She denies abdominal distension, back-ache, and constipation. She has not had her usual energy levels since before her last pregnancy.
Past Medical History (PMH):
Upon reviewing her past medical history, the gynecologist notes that her patient is a G5P5with four pregnancies within four years, the last infant having been delivered vaginally four months ago. All five pregnancies were unremarkable and without delivery complications. All infants were born healthy. Patient history also reveals a 3-year history of osteoarthritis in the left knee, probably the result of sustaining significant trauma to her knee in an MVA when she was 9 years old. When asked what OTC medications she is currently taking for her pain and for how long she has been taking them, she reveals that she started taking ibuprofen, three tablets each day, about 2.5 years ago for her left knee. Due to a slowly progressive increase in pain and a loss of adequate relief with three tablets, she doubled the daily dose of ibuprofen. Upon the recommendation from her nurse practitioner and because long-term ibuprofen use can cause peptic ulcers, she began taking OTC omeprazole on a regular basis to prevent gastrointestinal bleeding. Patient history also reveals a 3-year history of HTN for which she is now being treated with a diuretic and a centrally acting antihypertensive drug. She has had no previous surgeries.
Case Study Questions
Cardiovascular
Mr. W.G. is a 53-year-old white man who began to experience chest discomfort while playing tennis with a friend. At first, he attributed his discomfort to the heat and having had a large breakfast. Gradually, however, discomfort intensified to a crushing sensation in the sternal area and the pain seemed to spread upward into his neck and lower jaw. The nature of the pain did not seem to change with deep breathing. When Mr. G. complained of feeling nauseated and began rubbing his chest, his tennis partner was concerned that his friend was having a heart attack and called 911 on his cell phone. The patient was transported to the ED of the nearest hospital and arrived within 30 minutes of the onset of chest pain. In route to the hospital, the patient was placed on nasal cannula and an IV D5W was started. Mr. G. received aspirin (325 mg po) and 2 mg/IV morphine. He is allergic to meperidine (rash). His pain has eased slightly in the last 15 minutes but is still significant; was 9/10 in severity; now7/10. In the ED, chest pain was not relieved by 3 SL NTG tablets. He denies chills.
Case Study Questions
Submission Instructions:
Rubric
Discussion Rubric
Discussion Rubric
CriteriaRatingsPts
This criterion is linked to a Learning OutcomeIdentification of Main Issues, Problems, and Concepts
5 to >4.0 ptsDistinguished
Identifies and demonstrates a sophisticated understanding of the issues, problems, and concepts.
4 to >3.0 ptsExcellent
Identifies and demonstrates an accomplished understanding of most issues, problems, and concepts.
3 to >0.0 ptsFair
Identifies and demonstrates an acceptable understanding of most issues, problems, and concepts.
0 ptsPoor
Identifies and demonstrates an unacceptable understanding of most issues, problems, and concepts. Or nothing was posted.
5 pts
This criterion is linked to a Learning OutcomeUse of Citations, Writing Mechanics and APA Formatting Guidelines
3 ptsDistinguished
Effectively uses the literature and other resources to inform their work. Exceptional use of citations and extended referencing. High level of APA precision and free of grammar and spelling errors.
2 ptsExcellent
Effectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. Moderate level of APA precision and free of grammar and spelling errors.
1 ptsFair
Ineffectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. APA style and writing mechanics need more precision and attention to detail.
0 ptsPoor
Ineffectively uses the literature and other resources to inform their work. Unacceptable use of citations and extended referencing. APA style and writing mechanics need serious attention. Or nothing was posted.
3 pts
This criterion is linked to a Learning OutcomeResponse to Posts of Peers
2 ptsDistinguished
Student constructively responded to two other posts and either extended, expanded or provided a rebuttal to each.
1 ptsFair
Student constructively responded to one other post and either extended, expanded or provided a rebuttal.
0 ptsPoor
Student provided no response to a peer’s post.
2 pts
Total Points: 1
APA format
references no less than 6 years old
will be check through turn it in
Describe your clinical experience for this week.
Submission Instructions:
You see a child whose family believes in natural therapy for illnesses (e.g., diet therapy, massage, heat treatments).
How will you incorporate the family’s beliefs into the treatment of a child with an acute upper respiratory infection? With leukemia?
Submission Instructions:
Submitmyhomework.com is a unique service that provides guidance with different types of content. Please rest assured that the service is absolutely legal and doesn’t violate any regulations. It can be used for generating new ideas and thoughts for your own project, additional insight into the subject, or encouragement for further researches.
